Skip to content

A clinical study to compare two supplementary injection techniques using articaine in cases with symptomatic irreversible pulpitis.

COMPARATIVE EFFICACY OF 2 INJECTION METHODS WITH ARTICAINE FOR TREATMENT IN MANDIBULAR MOLARS WITH SYMPTOMATIC IRREVERSIBLE PULPITIS. A CONSORT RANDOMIZED DOUBLE-BLIND CLINICAL TRIAL : AN IN-VIVO STUDY.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024612
Enrollment
64
Registered
2020-04-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: supplimentery injection of madajet with articaine: 0.1 ml 4 times after inferior alveolar nerve block Control Intervention1: supplimentery injection of intraliagmentery with articaine:

Sponsors

Dr Harsh Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Systemically healthy patients. 2. Patients 18â??65 years old. 3. Not allergic to articaine or epinephrine. 4. No facial paresthesia. 5. Not taking any analgesic drug 6 hours before treatment. 6. Not taking any medication that interferes with anesthesia, such as tricyclic antidepressants and beta-blockers. 7. The absence of pathogenesis in areas planned for injection. 8. Not pregnant. 9. The absence of pathologic periodontal pockets during probing. 10. Patients with a mandibular molar tooth exhibiting symptomatic irreversible pulpitis. 11. Vital coronal pulp on access opening. 12. American society of anesthesiologist class 1 medical history. 13. The ability to understand the use of pain scale. 14. Patient experiencing greater than moderate pain and spontaneous and prolonged response to cold testing with Endo-Ice will be included in the study. 15. Teeth showing normal periapical view in the radiograph.

Exclusion criteria

Exclusion criteria: 1. A standard inferior alveolar nerve block injection will be performed using articaine 4% with epinephrine 1:100,000. Ten minutes after the injection, the patients will be asked about lip numbness. Patients without profound lip numbness will be excluded from the study because the block will be considered â??missedâ?? which will also be confirmed with electric pulp sensibility test. 2. Participants with periapical lesions, abscesses or cellulites at the relevant tooth, those with a medical treatment history or those having undergone root canal treatment for the relevant tooth will also be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Two compare the efficacy of two techniques which will be beneficial for the patients related to pain perceptionTimepoint: Cross sectional single time

Secondary

MeasureTime frame
pain perception with visual analouge scale.Timepoint: before and after intraligamentery and buccal and buccal infiltration

Countries

India

Contacts

Public ContactProf Naveen chhabra

Chhattishgarh Dental Collage and Research Institute

drnaveenchhabra@yahoo.com9426848178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026